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Abstract
Microarray data consists of mRNA expression levels of thousands of genes under certain conditions.
A difference in the expression level of a gene at two different conditions/phenotypes, such as cancerous
versus non-cancerous, one subtype of cancer versus another, before versus after a drug treatment, is
indicative of the relevance of that gene to the difference of the high-level phenotype. Each gene can
be ranked by its ability to distinguish the two conditions. We study how the single-gene classification
ability decreases with its rank (a Zipf’s plot). Power-law function in the Zipf’s plot is observed for the
four microarray datasets obtained from various cancer studies. This power-law behavior in the Zipf’s
plot is reminiscent of similar power-law curves in other natural and social phenomena (Zipf’s law).
However, due to our choice of the measure of importance in classification ability, i.e., the maximized
likelihood in a logistic regression, the exponent of the power-law function is a function of the sample
size, instead of a fixed value close to 1 for a typical example of Zipf’s law. The presence of this power-
law behavior is important for deciding the number of genes to be used for a discriminant microarray
data analysis.
1 Introduction
Not all of the more than 30,000 human genes and perhaps a multiple of that number of proteins [Venter,
et al., 2001; IHGSC, 2001] are expected to be useful for all situations. For a specialized phenotype, a
particular genetic disease, or a biological process of interest, only a portion of the genes are involved. Even
for the involved genes, their contribution to that phenotype (or disease, or process) varies: some genes can
be more important than others. The number of genes involved in a phenotype/disease/process also differs
from one case to another: some phenotypes require a large number of genes to contribute (polygenic),
others may only need a few (oligogenic). This theme has been discussed in the study of human genetic
diseases: those caused by mutation in one gene are called Mendalian or simple diseases, whereas those
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caused by multiple mutations in many genes, or due to an interplay between genetic susceptibility and
environmental factors, are called complex genetic diseases (see, e.g., [Haines, et al., 1998]).
Once a phenotype, a disease, or a biological process has been chosen, we may examine each gene’s
contribution to the phenotype/disease/process under study, and its “importance” can be ranked. This
ranking is a very common practice in quantitative analyses of natural and social phenomena. For example,
cities can be ranked by their population, companies can be ranked by revenue or profit, ecological disasters
can be ranked by the population of species being destroyed, etc. Plotting the measurement by which the
ranking is determined, versus the ranking number (1 for the best or the largest, etc., 2 for the second-best,
· · ·) is called a Zipf’s plot, originated from the work of George Zipf [Zipf, 1935, 1949].
Among the large number of Zipf’s plots drawn by Zipf, especially that of the frequency of word
occurrence in human language, it was observed that they tend to follow a power-law (algebraic) function:
y ∼ 1/rα, where r is the rank, y is the measurement that determines the rank, and α ≈ 1 the scaling
exponent. This power-law behavior is called Zipf’s law. Power-law Zipf’s plot where the value of α is not
close to 1 may be called a generalized form of Zipf’s law. Examples of Zipf’s law, besides those mentioned
above, include magnitude of earthquakes [Sornett, et al., 1996], popularity of webpage visits [Crovella &
Bestavros, 1997], usage of library books, frequency of key word search [Chen & Leimkuhler, 1986], etc.
More references on Zipf’s law can be found at an online resource at http://linkage.rockefeller.edu/wli/zipf.
This paper addresses the question of whether human genes can be ranked by their “importance” in
their contribution to a particular phenotype such as cancer. Once a measurement of the importance of a
gene is defined, we ask whether this measure of importance as a function of the rank follows an inverse
power-law function, i.e. Zipf’s law. There are two aspects of this study. Qualitatively, Zipf’s plot will show
whether or not the importance of genes, at least for a particular phenotype classification task, follows a
continuous spectrum. A discontinuous gap would separate “important” genes from “unimportant” ones.
Quantitatively, how fast the importance of genes falls off as a function of the rank provides information
on how many genes should be kept for this phenotypic classification.
The invention of the microarray (DNA chip) was a breakthrough in biotechnology (see, e.g., [Southern,
1996; Ekins & Chu, 1999]), which makes it possible to monitor the expression level of thousands of gene
products such as mRNA simultaneously. A comparison of these gene expression levels in cancerous as well
as normal tissues will point to genes relevant to oncogenesis. When each gene is examined individually,
the more its expression is different in cancerous tissues from that in normal tissues, the more relevant
this gene is to cancer development, and the more important it is for cancer classification. In this paper,
we use microarray data to rank the importance of genes, and Zipf’s plot of this measure of importance
is studied. Section 2 introduces the mathematical formula and quantities used in this paper; section 3
illustrates the likelihood-rank plots (Zipf’s plot) for the simplest cancer classifications (two-type); section
4 shows the Zipf’s plot for multiple-type classifications; section 5 shows the Zipf’s plot for paired samples
classification; section 6 discusses the issue concerning the exponent in the power-law plot; and section 7
contains other discussions.
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2 Measure of importance of genes in cancer classification: like-
lihood
The measurement we use for the importance of genes in cancer classification is the maximized like-
lihood, which is proportional to the probability of observing the data when a model is given, and when
the parameters in the model are adjusted to give the maximum value. Mathematically, likelihood L is
[Edwards, 1972]:
L = cP (D|M, θ), (1)
where D is all data points in a data set, M is a model, θ represents all parameters in the model, and c is
a proportional constant (often set to be 1). The maximized likelihood is
Lˆ = max
θ
L = cP (D|M, θˆ), (2)
where the ˆ represents a maximization/estimation procedure. The microarray data sets have the form
of {x1i, x2i, · · · , xpi, yi} (i = 1, 2, · · ·N). Each sample point i (one microarray experiment, one tissue
sample) contains measurements of (logarithm of ) mRNA expression level of p genes (p is typical of the
order of thousands), and y is a categorical label indicating a condition (e.g. cancerous or normal). The
raw data in a microarray experiment could be more complicated: one has to consider background noise,
normalization, and controls. These considerations depend on the type of chips: Stanford/cDNA array
with two fluorescence dyes [Schena, et al., 1995; Shalon et al., 1996] or Affymetrix/oligonucleotide arrays
with only one image intensity to measure but multiple oligonucleotide probes [Fodor, et al., 1991]. In this
paper, only the filtered/processed data are used and the subtle issue of scaling/normalization of the raw
data is not discussed.
The modelM is a classification model (classifier, predictor, discriminator, supervised learning machine),
that classifies the label y by the gene expression level {xj} (logarithm of an image intensity from the DNA
chip). We use a particularly simple classifier, the single-gene logistic regression:
P (yi = 1|xji) =
1
1 + e−aj−bjxji
. j = 1, 2, · · ·p, and i = 1, 2, · · ·N. (3)
In other words, the probability of a sample being in one class is a “sigmoid” or “logistic” function of the
(log) expression level. If the coefficient b is positive, larger expression levels lead to higher probabilities of
being the y = 1 label; if b < 0, larger expression level corresponds to the y = 0 label.
The likelihood of the whole data set is the product of these model-based probabilities (for a given
gene):
Lj =
N∏
i=1
[P (y = 1|xji)Iyi=1 + (1− P (y = 1|xji))Iyi=0] , j = 1, 2, · · ·p (4)
where I is the indicator function (1 or 0 depending on whether the condition is true or not). Eq.(4) is
maximized by adjusting the parameters in the model. The maximized likelihood Lˆ can then be used to
rank all genes: the larger the Lˆ, the higher the ranking.
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3 Zipf’s plot of classification likelihood
The binomial (two-class) logistic regression Eq.(3) has been applied to two microarray data sets. The
first is colon cancer data from Princeton University [Alon, et al., 1999]. The expression levels of 2000 genes
were available for 62 tissue samples: 40 cancerous and 22 normal. The second data set is leukemia data
from Whitehead Institute/MIT [Golub, et al., 1999]. Expression levels of 7129 genes were measured on
72 leukemia samples: 47 obtained from tissues of one subtype of leukemia, acute lymphoblastic leukemia
(ALL), and 25 from tissues of another subtype of leukemia, acute myeloid leukemia (AML). Although the
number of labels is 2 for both datasets, we distinguish cancerous from normal tissues in the first data set,
whereas distinguish one cancer subtype from another in the second data set.
For the colon cancer data, the single-gene maximized likelihood Eq.(4) for each gene was calculated and
ranked. The likelihood-rank plot (Zipf’s plot) is shown in Fig.1 in log-log scale. The power-law behavior
of the curve is clearly visible. Fitting the first 600 genes using a generalized form of Zipf’s law:
Lˆr ∼ 1/r
α, (5)
leads to exponent α ≈ 2.18, whereas the fitting of the top 1000 genes leads to α ≈ 2.10. The genes from
roughly rank 1000 to 2000 do not seem to follow the same power-law decay of the likelihood. As will be
discussed more later in this paper, the exponent α is not an intrinsic quantity for our likelihood-rank plots.
The reason is that the likelihood is a product of probabilities of N sample points Lr ∝ (p1p2 · · · pN )r ∼ p¯
N
r ;
if the per-sample averaged likelihood p¯r of rank-r gene does not change with the sample sizeN , the exponent
α is then a function of N : α ∼ −N log(p¯r)/log(r).
Fig.2 shows the Zipf’s plot of the second data set. Among the 72 samples, 38 are from bone marrow
tissues, and were separated as a training set in [Golub, et al., 1999]. These 38 samples were considered
to be more homogeneous, while the rest of the samples were from various sources or other tissue types
such as peripheral blood [Golub, et al., 1999], and may not be homogeneous. From Fig.2, the Zipf’s plot
obtained from the training set seems to follow a generalized form of Zipf’s law with a fitting exponent of
α ≈ 2.56 from the top 900 genes. The Zipf’s plot of all sample points seems to deviate from a power-law
trend around rank 100-200. As mentioned earlier, the exponent α from a bigger data set is indeed larger
than the exponent from a small data set.
When the top genes are examined, it was found that the top-ranking genes for the training set [Li &
Yang, 2001] and those for the overall set [Li, et al., 2001] may not be identical. For example, the top
performing gene for the 38-sample training set is No.4847, zyxin, a gene encoding the LIM domain protein
used in cell adhesion in fibroblasts [Golub, et al., 1999]. On the other hand, the best performing gene for
the 72-sample combined set is No. 1834, CD33 antigene which encodes cell surface proteins commonly
found in AML leukemia cells (see, e.g., [Lauria, et al., 1994]). The zyxin becomes the rank-4 gene for
the combined dataset. This difference reflects a certain degree of inhomogeneity between samples in the
training set and those in the remaining set (testing or validation set). Note from Fig.1 that for the training
set, genes from rank 3 to 9 exhibits similar likelihood, and form a flat step on the Zipf’s plot. Such steps
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are a dominant feature in the Zipf’s plot of the frequency of word occurrence in randomly generated texts
[Li, 1992].
4 Classification of multiple cancer classes
The logistic regression Eq.(3) for a two-class data set can be generalized to multiple classes: multinomial
logistic regression [Agresti, 1996]:
P (yi = I|xji) =
e−aI−bIxji
∑C
K=1 e
−aK−bKxji
j = 1, 2, · · · p, I = 1, 2, · · ·C, i = 1, 2, · · ·N , (6)
where the label y can be in one of the C classes, and there are two parameters for each class (though only
C− 1 class probabilities are independent). A gene is important (higher maximized likelihood) if it is more
able to distinguish all C classes simultaneously.
For this multiple-class analysis, we use the microarray data for lymphoma (Stanford University and
National Cancer Institute [Alizadeh, et al., 2000]). There are a total 96 tissue samples, with 66 cancerous
and 30 normal. Within the cancer samples, there are 46 diffuse large B-cell lymphoma (DLBCL), 9
follicular lymphoma (FL), 11 chronic lymphocyte leukemia (CLL). These 3 cancer subtypes plus the
normal are the 4 classes to be distinguished. In [Alizadeh, et al., 2000], it is also recommended that two
new subclasses of DLBCL can be defined based on the microarray data. These are the germinal centre
B-like DLBCL (GC-DLBCL) and the activated B-like DLBCL (A-DLBCL). The GC-DLBCL, A-DLBCL
subclasses plus the normal can be the 3 classes to be distinguished.
Fig.3 shows the Zipf’s plot of multinomial logistic regression likelihood for both the 4-class and the
3-class classification. The Zipf’s plot for the 3-class multinomial logistic regression follows a perfect power-
law function for all genes. No deviation from power-law behavior was observed even for the low-ranking
genes. The Zipf’s plot for the 4-class multinomial logistic regression, on the other hand, does not seem to
follow a power-law function. The fall off near the rank-200 gene is perhaps due to the computer roundoff
error since the value of likelihood at rank-200 is already as low as 10−39 (the likelihood is multipled by
1010 in Fig.3). The fitting of the top 200 genes by a power-law function is, however, very good.
5 Cancer treatment effect
Another interesting situation is provided by the data set from Stanford University and the Norwegian
Radium Hospital [Perou, et al., 2000]. Part of the data is the expression level of 8102 genes measured
before and after a 16-week course of doxorubicin chemotherapy [Perou, et al., 2000] on 20 patients. Naively,
one may consider these 40 microarray experiments as an example of binary logistic regression. However,
logistic regression in Eq.(3) does not apply because it requires samples to be independent of each other,
whereas microarray experiments done on the same patient are clearly not independent. This situation can
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be handled by the logistic regression of paired case-controls (case is a sample with label 1, and control is
a sample with label 0) [Breslow & Day, 1980]:
P (x(case)ji − x(control)ji) =
1
1 + ebj(x(case)ji−x(control)ji)
, j = 1, 2, · · · p, i = 1, 2, · · ·N . (7)
Note that the probability is no longer that for observing y – when a case sample and a control sample are
paired, their y value is fixed at 1 and 0 – but that of observing the difference of x’s. Also note that the
first parameter a is now zero.
Fig.4 shows the Zipf’s plot for genes in the breast cancer microarray data. The top three genes were
able to perfectly identify the chemotherapy effect – the expression level is always higher (or lower) before
the treatment than after in all 20 samples. The likelihood of a perfect fit is equal to 1. Unlike the previous
three plots, the likelihood of genes in Fig.4 does not follow a power-law function, or even a smooth function.
There seems to be a gap from the ranking of 19 to the ranking of 20-25. Fitting the two segments (from
4 to 19, and from 25 to 500) by power-law functions leads to different exponents (2.51 versus 1.77).
Plots like Fig.4 can be good news for a microarray data analysis, because there seems to be a separation
between “relevant” and “irrelevant” genes. Irrelevant genes are not important for distinguishing samples
before and after chemotherapy, and may be discarded for further analysis. Of course, this is only a
rough description of the gene set. A more systematic approach can be based on the framework of model
selection (see, e.g., [Burnham & Anderson, 1998]) or model averaging (see, e.g., [Geisser, 1993]). With
model selection, the expression level of different genes can be combined, and adding one gene increases the
number of parameters in the model by 1. The appropriate number of genes to be included in a classification
is the model with the best “model selection criterion” such as Akaike information criterion [Burnham &
Anderson, 1998] or Bayesian information criterion [Raftery, 1995], with a best balance between a larger
likelihood value and fewer numbers of parameters [Li & Yang, 2001, Li, et al., 2001]. With model averaging,
there is in principle no limitation on the number of genes to be included, but irrelevant genes have smaller
weights in an averaged classifier [Golub, et al., 1999, Li & Yang, 2001]. This makes the effective number
of genes used much smaller than the apparent number.
6 Scaling exponent
As mentioned earlier, the exponent of the inverse power-law fitting function for Zipf’s plot (Figs. 1-4)
depends on the sample size. The reason for this is that the measurement for the importance of a gene,
the sample classification likelihood, is a function of the sample size. Here we ask the question whether one
can define a normalized exponent. Since Lˆr ∼ 1/r
α, we can obviously draw Zipf’s plot for the per-sample
likelihood: p¯r = Lˆ
1/N
r ∼ 1/r(α/N). There is another consideration for classification of more than two
labels: it is unfair to compare per-sample classification likelihoods when the number of classes differs. Just
by random guess, the probability of classifying the label correctly for a binary-class case is 0.5, whereas
that for classifying C labels is 1/C. We can normalize the per-sample likelihood p¯r by the random-guess
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probability: lˆr = p¯r/(1/C) ∼ C/r
(α/N) with the same scaling exponent.
Fig.5 shows the Zipf’s plot of normalized per-sample likelihood lˆr for all data sets analyzed so far. These
curves can be compared in two ways. First, the performance of the top-ranking genes can be compared
by their lˆr’s. It is clear from Fig.5 that for the leukemia data, the performance obtained from the training
set is better than that obtained from the whole set, indicating a possible heterogeneity in the data set.
The performance of the top genes for the breast cancer data set is better (in terms of classification) than
that for the leukemia data set, which in turn is better than that for the colon cancer data set.
It is usually difficult to compare performance between a two-label classification and a multiple-label
classification, because it depends on the base-line expectation. Two base-line expectations (called null
models) were defined in [Li & Yang, 2001, Li, et al., 2001]: one is to randomly guess all classes with equal
probability, and another is to guess the class by the proportion of samples with this class in the data set.
In Fig.5, the first base-line expectation is used as the normalization factor. The performance of the 4-label
classification relative to this base-line expectation for the lymphoma data is considered to be better than
that of the 3-label classification, partly due to its low expectation.
Different data sets in Fig.5 can also be compared by the rate of falling of likelihood. The fall-off rate,
as measured by the scaling exponent α, ranges from 3 to 9 per 100 samples (i.e., α/N ≈ 0.03 − 0.09).
It is interesting that scaling exponents obtained from the leukemia data (both the whole data set and
the training set) and from the lymphoma data (two DLBCL subtypes plus normal) are almost identical
(around 65 - 67 per 100 samples). The breast cancer data is different from other data sets for falling faster
in the likelihood-rank plot.
7 Discussion
Results from Figs. 1-4 established that when microarray data is used to classify cancer tissues, the
classification likelihood of individual genes follows a generalized form of Zipf’s law. The reason that
these power-law functions in the Zipf’s plot do not have a scaling exponent equal to 1 is partly because
exponent α in Eq.(5) depends on the sample size N . Besides the issue of the exponent value, the overall
power-law trend is excellent: a perfect power-law function for all points in Fig.3 (3-label classification,
in 3.5 decades), a partial power-law fitting in a range of 2.5 decades (Fig.1), 3 decades (Fig.2), and 2
decades (Fig.3, 4-label classification), respectively. The only poor fitting by a power-law function is Fig.4.
The Zipf’s plot is flattern out for low-ranking genes in Figs. 1 and 2, while it drops off in Fig.3 (4-label
classification). Which functional form is more generic for low-ranking genes is not clear, perhaps our
results are sample-size sensitive.
Our Zipf’s plot can be compared to those obtained from biomolecular sequences. In [Gamow & Yc˘as,
1955], a Zipf’s plot for 20 amino acids usage in protein sequences was presented (in linear-linear scale).
Redrawing their data in log-log scale does not show any power-law behavior (result not shown). Recently,
it was claimed that oligonucleotide frequencies in DNA sequences follow Zipf’s law [Mantegna, et al., 1994].
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This paper drew criticism on its strong claim concerning the connection between Zipf’s law and human
language [Martindale & Konopka, 1995; Israeloff, et al., 1996, Bonhoeffer, et al., 1996a,1996b, Voss, 1996]:
one of the best counter-examples is Zipf’s law in money-typing texts [Li, 1992]. Also, the paper did not
show convincingly that the Zipf’s plot for oligonucleotide usage was better fitted by a power-law function
[Martindale & Konopka, 1996]: the deviation from the power-law fitting function can be gradual and
systematic, an indication that the power-law function is not the best choice of fitting function. Finally,
the scaling exponent in the power-law fitting function in [Mantegna, et al., 1994] is much smaller than 1
[Li, 1996]. In comparison, our Zipf’s plots in Figs 1-5 are a much better example of a generalized form of
Zipf’s law than those in [Gamow & Yc˘as, 1955] and [Mantegna, et al., 1994].
One may wonder whether the power-law behavior in Figs 1-5 can be derived by a simple random model.
In [Gamow & Yc˘as, 1955], the Zipf’s plot of the frequency of amino acids usage was compared to a “random
partition of a unit length” model. Suppose a unit interval is randomly partitioned into p segments (e.g.
p = 20 for 20 amino acids). These segments are ranked by their size L(1) = maxi(Li), L(2) = maxi(Li ∈
L − L(1)) · L(p) = mini(Li), etc. If this random partition is repeated, the mean value of the ranked size
can be shown to be [Gamow & Yc˘as, 1955]:
< L(r) >=
1
p
p+1−r∑
i=1
1
p+ 1− i
r = 1, 2, · · · p (8)
Drawing < L(r) > from Eq.(8) versus rank r shows that it is a straight line in linear(y)-log(x) plot, and
not a straight line in either log-log or log(y)-linear(x) plots (results not shown). Actually this analytic
result may not be applicable to our case, because we keep track of the performance of a given gene on all
samples, whereas in Eq.(8) the longest interval (or any given ranking interval) is averaged over all random
simulation. In any case, the power-law behavior in Fig.1-5 does not seem to be explainable by a simple
random model.
We may ask whether Zipf’s plot has any practical application for microarray data analysis. In informa-
tion retrieval [van Rijsbergen, 1975, Salton, 1988] and library/documentation science [Egghe & Rousseau,
1990], Zipf’s law is an important foundation that many applications are based upon. It is one of the
“bibliometric laws” [White & McCain, 1989] concerning regularities in bibliographies, lists of authors,
citation lists, etc. For the purpose of finding relevant, content-bearing words (“keywords”), common
(highest-ranking) and rare (lowest-ranking) words should be avoided [Luhn, 1957,1958].
Do we have a similar situation where the highest-ranking genes may not be interesting for cancer
classification? (Lowest-ranking genes are obviously not interesting.) Our ranking system is not really the
same as for word usage, since a discrimination or classification ability has already been included in our
definition, whereas it is not included in the word usage example. In this sense, our top ranking genes are in
fact most efficient for the purpose of cancer classification. On the other hand, if one is more interested in
subtle gene effects, not in the known main/dominant effect, it is perhaps useful to remove the well-known
genes from the list and examine other genes in a future study. This idea was not tried in our previous
analysis [Li & Yang, 2001, Li, et al., 2001].
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In conclusion, a generalized form of Zipf’s law was observed in microarray data for the likelihood
on cancer classification using single-gene logistic regression. We suspect that this power-law behavior is
generic rather than an exception. A rank-likelihood plot (Zipf’s plot) can be a useful quantitative tool for
discriminant microarray data analysis.
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Figure 1: Zipf’s plot for colon cancer and normal tissue classification: maximized likelihood of single-
variable logistic regression (Eq.(3)) for the top performing genes vs their ranks (in log-log scale).
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Figure 2: Zipf’s plot for leukemia subtype classification: maximized likelihood of single-variable logistic
regression (Eq.(3)) for the top genes vs their ranks, in log-log scale. The upper line is obtained from the
“training set” which contains 38 samples, and the lower line is from the “training plus testing set” which
contains 72 samples.
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Figure 3: Zipf’s plot for lymphoma subtypes classification: maximized likelihood of single-variable multi-
nomial logistic regression (Eq.(6)) for top-ranking genes vs. their ranks, in log-log scale. The upper line is
for the 3-class classification (GC-DLBCL, A-DLBCL, normal), and the lower line is for the 4-class situation
(DLBCL, FL, CLL, normal).
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Figure 4: Zipf’s plot for the breast cancer treatment effect: maximized likelihood of single-variable paired
case-control logistic regression (Eq.(7)) for top genes vs. their rank (in log-log scale).
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Figure 5: Normalized, per-sample maximum likelihood (lˆr = Lˆ
1/N
r /(1/C)) where C is the number of
classes (e.g., C = 2 for binomial logistic regression) for top genes vs. gene ranks, for all data sets. The
corresponding Lˆr vs rank plots are in Figs. 1-4.
